Physician

Lisa S Bunin, MD

According to 2025 Medicare claims, Lisa Bunin, MD (NPI: 1154397875) practices ophthalmology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. Bunin uses personal NPI as billing NPI and primary practice location at 18104-2258.

Bunin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 387 traditional Medicare patients, billed 5,211 HCPCS/CPT codes, and received $411,931 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,403 prescription claims across 347 beneficiaries totaling $719,757 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 38 records totaling $917. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $267,884 to $411,931. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$323K$646K2015 Medicare payment: $267,884 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $273,029 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $257,128 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $255,225 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $378,399 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $344,609 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $558,725 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $569,175 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $645,615 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $411,931 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154485,258$267,884
20164435,196$273,029
20174434,935$257,128
20184304,410$255,225
20194305,205$378,399
20203944,973$344,609
20214346,532$558,725
20224486,453$569,175
20234256,977$645,615
20243875,211$411,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$452K$903K2015 Drug cost: $633,967 (USD; Tot_Drug_Cst)2016 Drug cost: $723,242 (USD; Tot_Drug_Cst)2017 Drug cost: $753,989 (USD; Tot_Drug_Cst)2018 Drug cost: $753,167 (USD; Tot_Drug_Cst)2019 Drug cost: $903,109 (USD; Tot_Drug_Cst)2020 Drug cost: $745,809 (USD; Tot_Drug_Cst)2021 Drug cost: $754,538 (USD; Tot_Drug_Cst)2022 Drug cost: $762,791 (USD; Tot_Drug_Cst)2023 Drug cost: $714,869 (USD; Tot_Drug_Cst)2024 Drug cost: $719,757 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154442,521$633,967
20164412,403$723,242
20174272,196$753,989
20184041,896$753,167
20194102,000$903,109
20203731,683$745,809
20213751,536$754,538
20223711,464$762,791
20233251,439$714,869
20243471,403$719,757

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more340596$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more342847$65
92083Exam of visual field with extended testing331456$42
92134Imaging of retina338574$28
92250Photography of the retina341582$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine16910,335$211,085
LumiganBimatoprost31220,047$188,954
CombiganBrimonidine Tartrate/Timolol664,271$36,790
CyclosporineCyclosporine463,060$30,059
RhopressaNetarsudil Mesylate302,073$23,721

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$917ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lisa S. Bunin, MD?

Tedicare shows public-source Medicare data for Lisa S. Bunin, MD (NPI 1154397875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lisa S. Bunin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lisa S. Bunin, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Lisa S. Bunin, MD have Open Payments data?

Lisa S. Bunin, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.